W Advisors LLC’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
ECSS
ATO
W Advisors LLC's ABBV Position: Q2 2026 in Review
W Advisors LLC increased its AbbVie (ABBV) stake by 4% in Q2 2026, buying an estimated $21.9K and bringing the position to 2,648 shares worth $666K. The position accounts for 0.3% of the portfolio, ranked #72.
W Advisors LLC first reported a position in ABBV in Q4 2021 and has held it in 19 quarters since. 2,089 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- W Advisors LLC held 2,648 shares of AbbVie worth $666K as of Q2 2026.
- W Advisors LLC bought 102 AbbVie shares in Q2 2026, an estimated $21.9K.
- AbbVie made up 0.3% of W Advisors LLC's portfolio in Q2 2026, its #72 holding.
- W Advisors LLC first reported a position in AbbVie in Q4 2021 and has held it in 19 quarters since.
- 2,089 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on W Advisors LLC's 13F filing for Q2 2026, filed 31 Jul 2026.